This week we discuss the BiRT trial. It has long been a dogma to treat asymptomatic bacteriuria in kidney transplant recipients. Let’s upend this accepted truth by discussing the BiRT trial.
This week, we will discuss the ongoing saga of blood pressure targets in patients with hypertension. This time its ESPRIT (Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing Risk of Vascular Events) making a case for case for intensive BP control in most hypertensive individuals, including those with a history of diabetes and stroke.